Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Genet Mol Res ; 15(1)2016 Mar 31.
Article in English | MEDLINE | ID: mdl-27051034

ABSTRACT

The aim of this study was to use multivariate methods and Pearson and partial correlations to disregard phenotypic characteristics that contribute little to differentiation between Brachiaria ruziziensis genotypes. Eighty-one genotypes of B. ruziziensis were assessed in completely randomized blocks with three replications. Ten phenotypic characteristics were assessed: plant height, leaf length, leaf width, sheath length, length of the flower stem, length of the inflorescence axis, number of racemes per inflorescence, length of the basal raceme, number of spikelets per basal raceme, and width of the rachis. The best traits for differentiation between genotypes were determined by assessing relative contribution to diversity, canonical variables, as well as Pearson and partial correlations. Four canonical variables were found to account for 57% of the overall variation, while plant height, sheath length, and number of racemes per inflorescence were considered traits that could potentially be disregarded in future assessments.


Subject(s)
Brachiaria/genetics , Genetic Variation , Genotype , Phenotype , Brachiaria/growth & development , Plant Breeding , Quantitative Trait, Heritable
2.
Toxicon ; 72: 102-12, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23792453

ABSTRACT

Members of the spider genus Lasiodora are widely distributed in Brazil, where they are commonly known as caranguejeiras. Lasiodora spider venom is slightly harmful to humans. The bite of this spider causes local pain, edema and erythema. However, Lasiodora sp. spider venom may be a source of important pharmacological tools. Our research group has described previously that Lasiodora sp. venom produces bradycardia in the isolated rat heart. In the present work, we sought to evaluate the vascular effect of Lasiodora sp. venom and to isolate the vasoactive compounds from the venom. The results showed that Lasiodora spider venom induced a concentration-dependent vasodilation in rat aortic rings, which was dependent on the presence of a functional endothelium and abolished by the nitric oxide synthase (NOS) inhibitor L-NAME. Western blot experiments revealed that the venom also increased endothelial NOS function by increasing phosphorylation of the Ser¹¹77 residue. Assay-directed fractionation isolated a vasoactive fraction from Lasiodora sp. venom. Mass spectrometry (MS) and nuclear magnetic resonance (NMR) assays identified a mixture of two compounds: adenosine diphosphate (ADP, approximately 90%) and adenosine monophosphate (AMP, approximately 10%). The vasodilator effects of Lasiodora sp. whole venom, as well as ADP, were significantly inhibited by suramin, which is a purinergic P2-receptor antagonist. Therefore, the results of the present work indicate that ADP is a main vasodilator component of Lasiodora sp. spider venom.


Subject(s)
Adenosine Diphosphate/pharmacology , Spider Venoms/chemistry , Spiders/chemistry , Vasodilator Agents/pharmacology , Adenosine Diphosphate/chemistry , Adenosine Monophosphate/chemistry , Animals , Blotting, Western , Chemical Fractionation , Endothelium/drug effects , In Vitro Techniques , Mass Spectrometry , NG-Nitroarginine Methyl Ester/metabolism , Nitric Oxide Synthase/metabolism , Nuclear Magnetic Resonance, Biomolecular , Phosphorylation/drug effects , Rats , Suramin/chemistry , Vasodilation/drug effects , Vasodilator Agents/chemistry
3.
Br J Pharmacol ; 161(7): 1458-71, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20942845

ABSTRACT

BACKGROUND AND PURPOSE: Vasculopathies represent the main cause of morbidity and mortality in diabetes. Vascular malfunctioning in diabetes is associated with abnormal vasoconstriction and Ca(2+) handling by smooth muscle cells (SMC). Phosphatidylinositol 3-kinases (PI3K) are key mediators of insulin action and have been shown to modulate the function of voltage-dependent L-type Ca(2+) channels (Ca(V) 1.2). In the present work, we investigated the involvement of PI3K signalling in regulating Ca(2+) current through Ca(V) 1.2 (I(Ca,L) ) and vascular dysfunction in a mouse model of type I diabetes. EXPERIMENTAL APPROACH: Changes in isometric tension were recorded on myograph. Ca(2+) currents in freshly dissociated mice aortic SMCs were measured using the whole-cell patch-clamp technique. Antisense techniques were used to knock-down the PI3Kδ isoform. KEY RESULTS Contractile responses to phenylephrine and KCl were strongly enhanced in diabetic aorta independent of a functional endothelium. The magnitude of phenylephrine-induced I(Ca,L) was also greatly augmented. PI3Kδ expression, but not PI3Kα, PI3Kß, PI3Kγ, was increased in diabetic aortas and treatment of vessels with a selective PI3Kδ inhibitor normalized I(Ca,L) and contractile response of diabetic vessels. Moreover, knock-down of PI3Kδin vivo decreased PI3Kδ expression and normalized I(Ca,L) and contractile response of diabetic vessels ex vivo. CONCLUSIONS AND IMPLICATIONS: Phosphatidylinositol 3-kinase δ was essential to the increased vascular contractile response in our model of type I diabetes. PI3Kδ signalling was up-regulated and most likely accounted for the increased I(Ca,L,) leading to increased vascular contractility. Blockade of PI3Kδ may represent a novel therapeutic approach to treat vascular dysfunction in diabetic patients.


Subject(s)
Calcium Channels, L-Type/metabolism , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Type 1/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Animals , Aorta/physiopathology , Calcium/metabolism , Class I Phosphatidylinositol 3-Kinases , Diabetes Mellitus, Experimental/physiopathology , Diabetes Mellitus, Type 1/physiopathology , Male , Mice , Mice, Inbred C57BL , Muscle Contraction , Muscle, Smooth, Vascular/physiopathology , Myocytes, Smooth Muscle/physiology , Patch-Clamp Techniques , Phosphoinositide-3 Kinase Inhibitors , Receptors, Adrenergic, alpha-1/metabolism , Signal Transduction , Up-Regulation , Vasoconstriction , Vasodilation
4.
Br J Pharmacol ; 133(6): 849-58, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11454658

ABSTRACT

The hypotensive and vasorelaxant effect of dioclein in resistance mesenteric arteries was studied in intact animals and isolated vessels, respectively. In intact animals, initial bolus administration of dioclein (2.5 mg kg(-1)) produced transient hypotension accompanied by an increase in heart rate. Subsequent doses of dioclein (5 and 10 mg kg(-1)) produced hypotensive responses with no significant change in heart rate. N(G)-nitro-L-arginine methyl ester (L-NAME) did not affect the hypotensive response. In endothelium-containing or -denuded vessels pre-contracted with phenylephrine, dioclein (5 and 10 mg kg(-1) produced a concentration-dependent vasorelaxation (IC(50)=0.3+/-0.06 and 1.6+/-0.6 microM, respectively) which was not changed by 10 microM indomethacin. L-NAME (300 microM) produced a shift to the right. Dioclein was without effect on contraction of vessels induced by physiological salt solution (PSS) containing 50 mM KCl and the concentration dependence of dioclein's effect on phenylephrine induced contraction was shifted to the right in vessels bathed in PSS containing 25 mM KCl. Tetraethylammonium (10 mM) and BaCl(2) (1 mM) increased the IC(50) for dioclein-induced vasorelaxation without affecting the maximal response (E(max)). Charybdotoxin (100 nM), 4-aminopyridine (1 mM) and iberiotoxin (100 nM) increased the IC(50) and reduced the E(max). Apamin (1 microM) reduced the E(max) without affecting the IC(50). Dioclein produced a hyperpolarization in smooth muscle of mesenteric arteries with or without endothelium (7.7+/-1.4 mV and 12.3+/-3.6 mV, respectively). In conclusion dioclein lowered arterial pressure probably through a decrease in peripheral vascular resistance. The underling mechanism implicated in the vasorelaxant effect of dioclein appears to be the opening of K(Ca) and Kv channels and subsequent membrane hyperpolarization.


Subject(s)
Analgesics/pharmacology , Flavanones , Flavonoids/pharmacology , Hypotension/chemically induced , Mesenteric Arteries/drug effects , Potassium Channels/drug effects , Vasodilation/drug effects , 4-Aminopyridine/pharmacology , Animals , Apamin/pharmacology , Barium Compounds/pharmacology , Charybdotoxin/pharmacology , Chlorides/pharmacology , Consciousness , Dose-Response Relationship, Drug , Endothelium, Vascular/physiology , Enzyme Inhibitors/pharmacology , Glyburide/pharmacology , Hemodynamics/drug effects , In Vitro Techniques , Male , Membrane Potentials/drug effects , Mesenteric Arteries/physiology , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/physiology , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Peptides/pharmacology , Potassium Channel Blockers , Potassium Channels/metabolism , Potassium Chloride/pharmacology , Rats , Rats, Wistar , Tetraethylammonium/pharmacology , Time Factors , Vascular Resistance
SELECTION OF CITATIONS
SEARCH DETAIL
...